 |
Life Therapeutics to Appoint Independent Expert to Value Kedrion Transaction
AUG 17, 2007 11:06 - Article Views: 1,310
Life Therapeutics (ASX: LFE) today announced that the company has resolved to appoint an Independent Expert to provide an independent valuation on the proposed transaction with Kedrion S.p.A ("Kedrion"), pursuant to the terms announced on 30 July 2007. This will include an assessment of the value of LFE's equity stake in Kedrion. |
 |
|
Life Therapeutics to Deliver on Vertical Integration Strategy Through Partnership with Leading Fractionator
JUNE 25, 2007 10:21 - Article Views: 1,963
Life Therapeutics (ASX: LFE) today provided details of an agreement (the "Agreement") with Kedrion S.p.A ("Kedrion"), a leading European speciality pharmaceutical company and Italy's largest fractionator, that will enable the company to deliver on its strategy to become a vertically integrated operator. Under the terms of the Agreement, Life Therapeutics will take up a 5.5% equity stake in Kedrion and will divest assets from its Life Sera business into a new joint venture company with Kedrion ("Newco"). |
|
|
Life Therapeutics Update on Status of Heads of Agreement with European Fractionator
MAY 31, 2007 09:19 - Article Views: 1,273
On 19 March 2007 Life Therapeutics (ASX: LFE) (PNK: LFEFY) announced that it had entered into a non-binding Heads of Agreement with a European fractionator in relation to a proposed transaction. At that time, the company granted to the European fractionator exclusive negotiation rights up until 1 June 2007. |
|
|
Life Therapeutics Signs New Two Year Contract Valued up to A$12M per year
OCT 24, 2006 21:05 - Article Views: 1,428
Life Therapeutics (ASX: LFE)(PNK: LFEFY) has signed a new two year contract to produce hyperimmune plasma for a major fractionator. The value of the contract ranges from a minimum of A$4M up to A$12M per year for two years. |
|
|
Life Therapeutics Rolls Out Donor Computer System To Collection Centers On The West Coast of USA
OCT 15, 2006 11:56 - Article Views: 1,565
Donor Computer System now rolled out to all Collection Centers ATLANTA - 11 October, 2006 - Life Therapeutics (ASX: LFE) has now successfully completed the computerisation of the 5 West Coast plasma collection centres. |
|
|
Life Therapeutics Paves Their Way to a NASDAQ Listing With Sale of Sydney Property
SEP 12, 2006 12:04 - Article Views: 2,321
Life Therapeutics (ASX: LFE)(PNK: LFEFY) announced today that it has completed the sale of the Frenchs Forest building for A$9.25m to a fund controlled by MacarthurCook Ltd (ASX: MCK). |
|
|
Life Therapeutics to Provide Anti-Anthrax Plasma
SEP 6, 2006 11:48 - Article Views: 955
Life Therapeutics (ASX: LFE) will supply Cangene Corporation with Anti-Anthrax plasma for Cangene to produce an Anti-Anthrax hyperimmune for the U.S. Department of Health and Human Services. |
|
|
Life Therapeutics Opens Two New US Plasma Collection Centers
JULY 26, 2006 16:36 - Article Views: 1,034
Life Therapeutics (ASX: LFE) announced today that it has signed leases to open two new donor collection centers: one in Sacramento and the second in Long Beach in California. It is expected that these centers will become operational at the end of August 2006. |
|
|
Life Therapeutics Generates A$3.5m Free Cash On Sale of Frenchs Forest Building
JULY 18, 2006 00:27 - Article Views: 2,501
Life Therapeutics (ASX: LFE) announced today that it has exchanged contracts with MacarthurCook Ltd (ASX: MCK) for the sale of its Frenchs Forest building. |
|
